Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma

Journal of Drugs in Dermatology, Feb, 2007 by Tania Cestari, Lucie Adjadj, Margaret Hux, Maria Regina Shimizu, Vincent Pierre Rives

27. Pearce DJ, Nelson AA, Fleischer AB, Balkrishnan R, Feldman SR. The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies. J Dermatolog Treat. 2006;17:29-37.

28. Miller DW, Feldman SR. Cost-effectiveness of moderate-to-severe psoriasis treatment. Expert Opin Pharmacother. 2006;7:157-167.

29. Kono T, Ercocen AR, Chan HH, et al. Treatment of phacomatosis pigmentovascularis: a combined multiple laser approach. Dermatol Surg. 2003;29:642-646.

30. Balkrishnan R, Kelly AP, McMichael A, Torok H. Improved quality of life with effective treatment of facial melasma: the PIGMENT study. J Drugs Dermatol. 2004;3:377-381.

31. Feldman SR, Sahu S, Fleischer AB Jr, Dezii CM. Per-gram cost of medication is by itself a poor indicator for comparing costs of different psoriasis treatments: a retrospective cohort study of the cost of psoriasis treatment with topical corticosteroids versus topical calcipotriene. J Cutan Med Surg. 2000;4:121-125.

ADDRESS FOR CORRESPONDENCE

Lucie Adjadj

Galdcrma International

20 avenue Andre Prothin

F-92927 La Defense cedex

France

Phone: 01 58 86 45 92

Fax: 01 58 86 45 29

e-mail: Lucie.adjadj@galderma.com

Tania Cestari MD PhD, (a) Lucie Adjadj, (b) Margaret Hux MSc, (c) Maria Regina Shimizu, (d) Vincent Pierre Rives PharmD (b)

a. Associate Professor of Dermatology, University of Rio Grande do Sul, Porto Alegre, Brazil

b. Galderma International, La Defense, France

c. i3 Innovus, Burlington, Ontario, Canada

d. Galderma Brasil Ltda, Sao Paulo, Brazil